期刊文献+

伴有失代偿性心力衰竭慢性肾脏病的正性肌力药物的选择与应用 被引量:2

Application of inotropic agents in patients with chronic kidney disease accompanied by decompensated
下载PDF
导出
摘要 正性肌力药物是治疗失代偿性心力衰竭的常用药物,但慢性肾脏病患者如何选择与应用,缺乏指导性意见。本文在介绍不同种类正性肌力药物的药理作用基础上,基于循证证据评价正性肌力药物治疗伴有失代偿性心力衰竭的慢性肾脏病患者的获益与风险,旨在为临床医生合理应用正性肌力药物提供借鉴和参考。 Inotropic agents are commonly used in the treatment of decompensated heart failure,but there is still no guidance on how to choose and apply them in patients with chronic kidney disease(CKD).Based on evidence-based medicine,this paper introduces the pharmacological effects of different kinds of inotropic agents and evaluated the benefits and risks of them in the treatment decompensated heart failure in CKD patients.This papers aim is to provide reference for clinicians in rational application of inotropic agents.
作者 孙雪峰 SUN Xue-feng(Department of Nephrology,First Medical Center of Chinese PLA General Hospital,State Key Laboratory of Kidney Diseases,National Clinical Research Center for Kidney Diseases,Beijing 100853,China)
出处 《中国血液净化》 CSCD 2022年第10期705-708,共4页 Chinese Journal of Blood Purification
基金 国家自然科学基金面上项目(92049103,81870463)。
关键词 正性肌力药物 慢性肾脏病 失代偿性心力衰竭 Inotropic agents Chronic kidney disease Decompensated heart failure
  • 相关文献

同被引文献23

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部